Role of Ultrasound Guided Transversus Abdominis Plane Block in Pain Control After Hepatectomy
NCT ID: NCT06224179
Last Updated: 2024-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2024-02-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to assess the postoperative analgesic efficacy of ultrasound-guided Transversus Abdominis Plane (TAP) block using oblique subcostal and posterior approaches in hepatectomy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-Guided QL Block Versus TAP Block For Post-Operative Pain In Lower Abdominal Surgeries
NCT06978179
Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty
NCT01604694
Ultrasound Guided TAP Block for Postoperative Analgesia After Abdominal Surgery.
NCT02976597
Retrolaminar Block Versus Tab Block in Abdomioasty
NCT06265402
Ultrasound Guided Quadratus Lumborum Block Versus Transversus Abdominis Plane Block as Postoperative Analgesia in Patients Undergoing Abdominal Cancer Surgery.
NCT05533424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postoperative pain management for patients undergoing hepatic resection is a challenge due to the risk of perioperative liver dysfunction.TAP block is a promising regional analgesic technique. This study aimed to evaluate the effect of US-guided subcostal approach versus combination of both subcostal and posterior approaches of TAP block
The patients will be randomly divided into two groups :
group A will recieve oblique subcostal TAP block and group B will recieve both subcostal and posterior TAP block .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Group A received ultrasound guided subcostal TAP block with 30 ml of local anesthetics and additives
ultrasound guided subcostal TAP block
patients will be randomly divided into two groups using a computer generated random number chart.
Group A received ultrasound guided subcostal TAP block,
Group B
Group B received ultrasound guided both subcostal and posterior TAP block with 30 ml of local anesthetics and additives at each side
ultrasound guided combined posterior and subcostal TAP block
patients will be randomly divided into two groups using a computer generated random number chart.
Group B received ultrasound guided combined posterior and subcostal TAP block,
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound guided subcostal TAP block
patients will be randomly divided into two groups using a computer generated random number chart.
Group A received ultrasound guided subcostal TAP block,
ultrasound guided combined posterior and subcostal TAP block
patients will be randomly divided into two groups using a computer generated random number chart.
Group B received ultrasound guided combined posterior and subcostal TAP block,
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of Allergic reactions to study drugs.
* Opioid or analgesic abuse, and chronic treatment with opioids, or non-steroidal anti-inflammatory drugs.
* History of bleeding tendency or coagulopathy .
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed wagih Ezzat deusouky
lecturer of anesthesia
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M S 96/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.